Diindolylmethane in Treating Patients With Abnormal Cervical Cells

NCT00462813 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

3000

Enrollment

OTHER

Sponsor class

Conditions

Cervical Cancer
Precancerous Condition

Interventions

DRUG: oral microencapsulated diindolylmethane
GENETIC: polymerase chain reaction
OTHER: cervical Papanicolaou test
OTHER: cytology specimen collection procedure
PROCEDURE: colposcopic biopsy

Sponsor

Barts and the London School of Medicine and Dentistry